Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Promoting excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The 'ESC in Myanmar' programme is part of a series of international ESC educational courses built around a global network of international partnerships.
In close collaboration with the Asean Federation of Cardiology, the ESC brings highlights in key topics from ESC Congress 2016 to Myanmar as part of the Final Programme of the Asean Federation of Cardiology Congress 2016.
If you wish to attend these sessions you should register for the AFC Congress - save if you register before 15 July:
Chairpersons: F. Pinto (Portugal) 12:30-12:40 Welcome and introduction - F. Pinto (Portugal) 12:40-13:00 Real world evidence NOACs – An update - J. Tan (Singapore)13:00-13:20 NOACs – Clinical practice data from Asia - N. Heng Joo (Singapore)13:20-13:40 Anticoagulation care 3.0 - F. Pinto (Portugal) 13:40-14:00 Panel Discussion - F. Pinto (Portugal)
Chairpersons: tbc12:30-12:35 Welcome and introduction - TBC 12:35-13:00 Anticoagulation in AF: The unmet clinical need - TBC - Current clinical practice in Myanmar in SPAF - The unmet clinical need in current standard of care13:00-13:40 Rivaroxaban in SPAF: from RCTs to RWEs - TBC - Update ESC AF guidelines 2016 - Key highlights of ROCKET AF - RWE of rivaroxaban eg: XANTUS, US PMDD, REVISIT US 13:40-14:00 Panel Q&A - TBC
Chairpersons: F. Pinto (Portugal) & R. Ng (Singapore)
Pyay Room (L4)
14:00-14:30 Interventional cardiology. F. Pinto (Portugal)
14:30-15:00 Prevention. G. Derumeaux (France)
15:00-15:30 Heart failure. M. Komajda (France)
Chairpersons: M. Komajda (France) & M. Rosli (Malaysia)
16:00 -16:20 Heart Failure - M. Komajda (France)
16:20-16:30 Discussion - D. Sim (Singapore)
16:30-16:50 Prevention - G. Derumeaux (France)
16:50-17:00 Commentary - A. Santoso (Indonesia)
17:00-17:20 Atrial Fibrillation - F. Pinto (Portugal)
17:20-17:30 Commentary - C.K. Ching (Singapore)
Novotel Yangon Max
459 Pyay Road, Kamayut Tsp
The ESC Global Scientific Activities Committee are supported by Bayer and Boehringer Ingelheim in the form of an unrestricted educational grant.